BRTX BioRestorative Therapies, Inc.
$2.67▼ -3.26%
Healthcare
Other
After hours
$2.74▲ +2.62%
Sep 11, 6:20 PM ET
Volume 9.4K
Avg Volume (10D) 41.4K
Key Metrics & Fundamentals
Market Cap
$3.69M
P/E Ratio
–
Div Yield
–%
52W Range
2.61 - 34.60
% vs 50 MA
485.91%
% vs 200 MA
388.47%
RSI-14
90.6
MACD Histogram
+0.3100
Beta (1Y vs SPY)
-5.11
Free Cash Flow
-$3.81M
Gross Rev
$23,170
Gross Profit
$15,785
EBITDA
-$4.56M
COGS
$7,385
Operating Exp
$3.40M
Operating Income
-$3.39M
EBIT
-$3.39M
Pretax Income
-$2.15M
Net Income
-$2.15M
EPS (Diluted)
-0.12
Price & Volume History
Loading chart…
Recent News
BioRestorative Therapies Announces Reverse Stock Split
GlobeNewswire · Sep 2, 2026 9:27 PM
Alvotech (ALVO) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 19, 2026 9:45 PM
Clene Inc. (CLNN) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 14, 2026 1:20 PM
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 6, 2026 12:20 PM
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
GlobeNewswire · Jun 25, 2026 12:15 PM
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth
GlobeNewswire · Jun 18, 2026 12:15 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See BRTX's money flow as a full page
Social Sentiment
No Reddit posts found for BRTX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.